Agilent Technologies, Inc. (A)
Healthcare
$153.43-3.50%Close
BUYBULL · day 7
$153.43-3.50%
Key stats
- Market cap
- $43.3B
- Avg volume
- 2.2M
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
11,685 Shares in Agilent Technologies, Inc. $A Acquired by EP Wealth Advisors LLC

Allworth Financial LP Takes $2.71 Million Position in Agilent Technologies, Inc. $A

Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS

Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore

Advisors Capital Management LLC Purchases New Position in Agilent Technologies, Inc. $A

Agilent Technologies, Inc. $A Shares Bought by Bank of New York Mellon Corp

MDT vs. A: Which Stock Should Value Investors Buy Now?

BIP Wealth LLC Makes New $834,000 Investment in Agilent Technologies, Inc. $A

Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A.

Comparing Agilent Technologies (NYSE:A) & Many Bright Ideas Technologies (OTCMKTS:MBGNF)

Ashton Thomas Securities LLC Buys 6,387 Shares of Agilent Technologies, Inc. $A

Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Agilent Increases Its Investment in HALO X-ray Technologies

Dividend Champion, Contender, And Challenger Highlights: Week Of July 19

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

Alpha and Omega Semiconductor Unveils AmpStack™ Packaging: A Leap Forward in MOSFET Power Density